Home > Events > Past Conferences > CLIB International Conference CIC2023

CLIB International Conference CIC2023

February 14-15, 2023 | USA

CLIB International
Under the title “Setting sail for industrial implementation” we will discuss how biotechnology can make the difference on a larger scale. As a society, we are facing major challenges in the coming years to achieve our climate and sustainability goals.

Spotlight

Multi-Specific Monoclonal Antibodies

The reason for the rapid expansion and development of the therapeutic antibody sector is the capacity of monoclonal antibodies to precisely bind a target antigen and neutralise or promote its activity. The efficacy and safety.


OTHER PAST CONFERENCES

8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

February 8-9, 2023 | USA

MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

Bioactive Lipids in Cancer, Inflammation and Related Diseases

October 30-November 2, 2022 | USA

The conference series on Bioactive Lipids in Cancer, Inflammation and Related Diseases was started in 1989 when its first conference was held in Detroit, Michigan. Subsequent meetings were held around the globe with the next conference scheduled forOct. 30 – Nov. 2, 2022 in New Orleans, Louisiana, at the Hilton New Orleans Riverside hotel.

BIO-Europe Spring 2023

March 20-22, 2023 | Switzerland

This year, the program will focus on three tracks with a mix of the fireside chat and panel discussion. Bringing the latest insight into some therapeutic areas, challenges and learnings from the business development aspects, and various perspectives from the ecosystems

Primary Care: Family Medicine, Sports Medicine, and Geriatrics

December 5-8, 2022 | USA

Determine which screening tests are indicated for particular patients, according to USPSTF guidelines. Employ Guideline recommendations presented for common disorders such as HBP, Lipids, STD’s, Cancers-lung, Cx, Breast, etc; AAA, Hep B & C; T2DM, etc, Advise your patients regarding vitamins and supplements as per the USPSTF and Evidence, Order appropriate immunizations for adult patients as per the ACIP and CDC Schedules.

8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

February 8-9, 2023 | USA

MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

Bioactive Lipids in Cancer, Inflammation and Related Diseases

October 30-November 2, 2022 | USA

The conference series on Bioactive Lipids in Cancer, Inflammation and Related Diseases was started in 1989 when its first conference was held in Detroit, Michigan. Subsequent meetings were held around the globe with the next conference scheduled forOct. 30 – Nov. 2, 2022 in New Orleans, Louisiana, at the Hilton New Orleans Riverside hotel.

BIO-Europe Spring 2023

March 20-22, 2023 | Switzerland

This year, the program will focus on three tracks with a mix of the fireside chat and panel discussion. Bringing the latest insight into some therapeutic areas, challenges and learnings from the business development aspects, and various perspectives from the ecosystems

Primary Care: Family Medicine, Sports Medicine, and Geriatrics

December 5-8, 2022 | USA

Determine which screening tests are indicated for particular patients, according to USPSTF guidelines. Employ Guideline recommendations presented for common disorders such as HBP, Lipids, STD’s, Cancers-lung, Cx, Breast, etc; AAA, Hep B & C; T2DM, etc, Advise your patients regarding vitamins and supplements as per the USPSTF and Evidence, Order appropriate immunizations for adult patients as per the ACIP and CDC Schedules.
More Past Conferences

Spotlight

Multi-Specific Monoclonal Antibodies

The reason for the rapid expansion and development of the therapeutic antibody sector is the capacity of monoclonal antibodies to precisely bind a target antigen and neutralise or promote its activity. The efficacy and safety.

resources

resource image

The Intersection of Biology and AI | Nasdaq Biotech Spotlight

video

resource image

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper

resource image

Avecho Biotechnology shares recent progress on vitamin K injection and CBD treatment

video